Duchenne Muscular Dystrophy Drug Fails in Phase 3

Duchenne Muscular Dystrophy Drug Fails in Phase 3
It has been designated orphan drug status in Europe, the United States, and Japan and in June 2013 was granted Breakthrough Therapy designation by the US Food and Drug Administration. In this phase 3, double-blind trial, called DMD114044, 186 boys … Read more on Medscape

Veterans chairman says Navy Yard shooter may have taken drug with
According to The Washington Post, Alexis was prescribed Trazodone, which is frequently used to treat depression. However, the National Institutes of Health say it's also meant to help with sleeplessness and schizophrenia. During the two visits Alexis … Read more on The Hill (blog)

Death takes a front seat in Astoria talk
And when it comes to planning one's medical future –advanced directives or Physician Orders for Life-sustaining Treatment (POLST) – the difference lies in what you desire and value versus what you want and need. “If I were talking just … People with … Read more on Daily Astorian